Predicting cancer outcomes with radiomics and artificial intelligence in radiology.
Kaustav BeraNathaniel BramanAmit GuptaVamsidhar VelchetiAnant MadabhushiPublished in: Nature reviews. Clinical oncology (2021)
The successful use of artificial intelligence (AI) for diagnostic purposes has prompted the application of AI-based cancer imaging analysis to address other, more complex, clinical needs. In this Perspective, we discuss the next generation of challenges in clinical decision-making that AI tools can solve using radiology images, such as prognostication of outcome across multiple cancers, prediction of response to various treatment modalities, discrimination of benign treatment confounders from true progression, identification of unusual response patterns and prediction of the mutational and molecular profile of tumours. We describe the evolution of and opportunities for AI in oncology imaging, focusing on hand-crafted radiomic approaches and deep learning-derived representations, with examples of their application for decision support. We also address the challenges faced on the path to clinical adoption, including data curation and annotation, interpretability, and regulatory and reimbursement issues. We hope to demystify AI in radiology for clinicians by helping them to understand its limitations and challenges, as well as the opportunities it provides as a decision-support tool in cancer management.
Keyphrases
- artificial intelligence
- deep learning
- big data
- machine learning
- papillary thyroid
- convolutional neural network
- squamous cell
- high resolution
- decision making
- lymph node metastasis
- palliative care
- magnetic resonance imaging
- squamous cell carcinoma
- type diabetes
- skeletal muscle
- rna seq
- electronic health record
- optical coherence tomography
- adipose tissue
- smoking cessation
- glycemic control